Skip to main content
Erschienen in: Tumor Biology 3/2011

01.06.2011 | Research Article

Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors

verfasst von: Luciana Regina Moreira, André Almeida Schenka, Paulo Latuf-Filho, André Lisboa Penná, Carmen S. P. Lima, Fernando Augusto Soares, Miriam Aparecida Silva Trevisan, José Vassallo

Erschienen in: Tumor Biology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Analysis of blood and lymphatic vessel in colorectal cancer is controversial in the literature, possibly due to variations in the methods of analysis. In this study, it was aimed to search for a reliable approach in the quantification of angio- and lymphangiovascular density and area as a prognostic factor and to compare such vessel counts in normal mucosa, adenomas and cancer. A retrospective study was performed on 60 sporadic colorectal cancer, 30 colorectal adenomas, and 10 colorectal non-neoplastic lesions. Archival tissues were submitted to immunohistochemical evaluation using antibodies to CD31, CD34, CD105, VEGF-A, VEGF-C, and D2-40. Microvessel density and total vascular area were determined by computer image analysis and values were compared in the three groups of lesions; the prognostic value of these parameters was evaluated in the group of colorectal cancer. Most markers showed progressive vessel counts from non-neoplastic tissue to carcinoma, both for microvessel density and total vascular area. Only microvessel density determined by CD34 in the central areas of the cancer correlated with recurrence/metastasis (p = 0.04) and survival (p = 0.02). Different methods of quantification (microvessel counting versus estimation of total vascular area), immunohistochemical markers (pan-endothelial marker versus neovessels and lymphatic markers), and areas of analysis (periphery versus inner portions of the lesion) were assessed using image analysis. The results corroborate the increase in vascularization of carcinoma and suggest that microvessel density determined by immunostaining for CD34 in the inner portion of the tumor might represent a prognostically relevant parameter in colorectal cancer.
Literatur
1.
Zurück zum Zitat Benson AB. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm. 2007;13:5–18. Review. Benson AB. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm. 2007;13:5–18. Review.
2.
Zurück zum Zitat Buyse M, Piedbois P. Should Dukes’ B patients receive adjuvant therapy? A statistical perspective. Semin Oncol. 2001;28:20–4.PubMedCrossRef Buyse M, Piedbois P. Should Dukes’ B patients receive adjuvant therapy? A statistical perspective. Semin Oncol. 2001;28:20–4.PubMedCrossRef
3.
Zurück zum Zitat Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005;9:777–94. Review.PubMedCrossRef Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005;9:777–94. Review.PubMedCrossRef
4.
Zurück zum Zitat Ono T, Miki C. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma. Am J Gastroenterol. 2000;95:1062–7.PubMedCrossRef Ono T, Miki C. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma. Am J Gastroenterol. 2000;95:1062–7.PubMedCrossRef
5.
Zurück zum Zitat Galizia G, Ferraracio F, Lieto E, et al. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery. Dis Colon Rectum. 2004;47:1904–14.PubMedCrossRef Galizia G, Ferraracio F, Lieto E, et al. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery. Dis Colon Rectum. 2004;47:1904–14.PubMedCrossRef
6.
Zurück zum Zitat Kojima M, Shiokawa A, Nobuyuki O, et al. Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGFA and VEGFC. Oncology. 2005;68:230–8.PubMedCrossRef Kojima M, Shiokawa A, Nobuyuki O, et al. Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGFA and VEGFC. Oncology. 2005;68:230–8.PubMedCrossRef
7.
Zurück zum Zitat Zheng S, Han MY, Xiao ZX, Peng JP, Dong Q. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol. 2003;9:1227–30.PubMed Zheng S, Han MY, Xiao ZX, Peng JP, Dong Q. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol. 2003;9:1227–30.PubMed
8.
Zurück zum Zitat Rmali KA, Puntis CA, Jiang WG. Tumor associated angiogenesis in human colorectal cancer. Colorectal Dis. 2006;9:3–14.CrossRef Rmali KA, Puntis CA, Jiang WG. Tumor associated angiogenesis in human colorectal cancer. Colorectal Dis. 2006;9:3–14.CrossRef
9.
Zurück zum Zitat Duff SE, Jeziorska M, Kumar S, Haboubi N, et al. Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Dis. 2007;9:793–800.PubMedCrossRef Duff SE, Jeziorska M, Kumar S, Haboubi N, et al. Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Dis. 2007;9:793–800.PubMedCrossRef
10.
Zurück zum Zitat Hu WG, Li JW, Feng B, et al. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Eur Surg Res. 2007;39:229–38.PubMedCrossRef Hu WG, Li JW, Feng B, et al. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Eur Surg Res. 2007;39:229–38.PubMedCrossRef
11.
Zurück zum Zitat Kaio E, Tanaka S, Kitadai Y, et al. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology. 2003;64:61–73.PubMedCrossRef Kaio E, Tanaka S, Kitadai Y, et al. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology. 2003;64:61–73.PubMedCrossRef
12.
Zurück zum Zitat Cao Y. Why and how do tumors stimulate lymphangiogenesis? Lymphat Res Biol. 2008;6:145–8. Review.PubMedCrossRef Cao Y. Why and how do tumors stimulate lymphangiogenesis? Lymphat Res Biol. 2008;6:145–8. Review.PubMedCrossRef
13.
Zurück zum Zitat Gao Y, Zhong WX, Mu DB, et al. Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors. Ann Surg Oncol. 2008;15:1117–23.PubMedCrossRef Gao Y, Zhong WX, Mu DB, et al. Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors. Ann Surg Oncol. 2008;15:1117–23.PubMedCrossRef
14.
Zurück zum Zitat Vermeulen PB, Van den Eynden GG, Huget P, et al. Prospective study of intramural microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer. 1999;79:316–22.PubMedCrossRef Vermeulen PB, Van den Eynden GG, Huget P, et al. Prospective study of intramural microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer. 1999;79:316–22.PubMedCrossRef
15.
Zurück zum Zitat Pavlopoulos PM, Konstantinidou AE, Agapitos E, et al. A morphometric study of neovascularization in colorectal carcinoma. Cancer. 1998;83:2067–75.PubMedCrossRef Pavlopoulos PM, Konstantinidou AE, Agapitos E, et al. A morphometric study of neovascularization in colorectal carcinoma. Cancer. 1998;83:2067–75.PubMedCrossRef
16.
Zurück zum Zitat Prall F, Gringmuth U, Nizze H, Barten M. Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histopathology. 2003;42:482–91.PubMedCrossRef Prall F, Gringmuth U, Nizze H, Barten M. Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histopathology. 2003;42:482–91.PubMedCrossRef
17.
Zurück zum Zitat Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, et al. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery. 2002;131:109–13.CrossRef Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, et al. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery. 2002;131:109–13.CrossRef
18.
Zurück zum Zitat Li C, Gardy R, Seon BK, et al. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer. 2003;88:1424–31.PubMedCrossRef Li C, Gardy R, Seon BK, et al. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer. 2003;88:1424–31.PubMedCrossRef
19.
Zurück zum Zitat Clasper S, Royston D, Baban D, et al. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res. 2008;68:7293–303.PubMedCrossRef Clasper S, Royston D, Baban D, et al. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res. 2008;68:7293–303.PubMedCrossRef
20.
Zurück zum Zitat Romani AA, Borghetti AF, Del Rio P, et al. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count. J Surg Oncol. 2006;93:446–55.PubMedCrossRef Romani AA, Borghetti AF, Del Rio P, et al. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count. J Surg Oncol. 2006;93:446–55.PubMedCrossRef
21.
Zurück zum Zitat Barresi V, Vitarelli E, Tuccari G, Barresi G. Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch Pathol Lab Med. 2008;132:1807–12.PubMed Barresi V, Vitarelli E, Tuccari G, Barresi G. Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch Pathol Lab Med. 2008;132:1807–12.PubMed
22.
Zurück zum Zitat Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434–40.PubMedCrossRef Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434–40.PubMedCrossRef
23.
Zurück zum Zitat Longatto-Filho A, Pinheiro C, Ferreira L, et al. Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Arch. 2008;452:133–8.PubMedCrossRef Longatto-Filho A, Pinheiro C, Ferreira L, et al. Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Arch. 2008;452:133–8.PubMedCrossRef
24.
Zurück zum Zitat Yan G, Zhou XY, Cai SJ, Zhang GH, et al. Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World J Gastroenterol. 2008;14:101–7.PubMedCrossRef Yan G, Zhou XY, Cai SJ, Zhang GH, et al. Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World J Gastroenterol. 2008;14:101–7.PubMedCrossRef
25.
Zurück zum Zitat Matsumoto K, Nakayama Y, Inoue Y, et al. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum. 2007;50:308–14.PubMedCrossRef Matsumoto K, Nakayama Y, Inoue Y, et al. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum. 2007;50:308–14.PubMedCrossRef
26.
Zurück zum Zitat Fogt F, Zimmerman RL, Ross HM, et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep. 2004;11:47–50.PubMed Fogt F, Zimmerman RL, Ross HM, et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep. 2004;11:47–50.PubMed
27.
Zurück zum Zitat International Union against Cancer /TNM Classification of Malignant Tumours (2009) 7th edition. Geneva, Switzerland. Available: http://www.uicc.org [accessed May 10, 2010]. International Union against Cancer /TNM Classification of Malignant Tumours (2009) 7th edition. Geneva, Switzerland. Available: http://​www.​uicc.​org [accessed May 10, 2010].
28.
Zurück zum Zitat Giatromanolaki A, Sivridis E, Koukourakis MI. Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol. 2006;29:408–17.PubMedCrossRef Giatromanolaki A, Sivridis E, Koukourakis MI. Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol. 2006;29:408–17.PubMedCrossRef
29.
Zurück zum Zitat Gao J, Knutsen A, Arbman G, et al. Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis. 2009;41:116–22.PubMedCrossRef Gao J, Knutsen A, Arbman G, et al. Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis. 2009;41:116–22.PubMedCrossRef
30.
Zurück zum Zitat Vermeulen PB, Gasparini G, Fox SB, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer. 2002;38:1564–79. Review.PubMedCrossRef Vermeulen PB, Gasparini G, Fox SB, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer. 2002;38:1564–79. Review.PubMedCrossRef
31.
Zurück zum Zitat Svagzdys S, Lesauskaite V, Pavalkis D, et al. Microvessel density as new prognostic cancer.marker after radiotherapy in rectal cancer. BMC Cancer. 2009;26:9–95. Svagzdys S, Lesauskaite V, Pavalkis D, et al. Microvessel density as new prognostic cancer.marker after radiotherapy in rectal cancer. BMC Cancer. 2009;26:9–95.
32.
Zurück zum Zitat Ma YL, Peng JY, Zhang P, Liu WJ, et al. Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer. Med Oncol. 2010;27(2):304–9.PubMedCrossRef Ma YL, Peng JY, Zhang P, Liu WJ, et al. Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer. Med Oncol. 2010;27(2):304–9.PubMedCrossRef
33.
Zurück zum Zitat Nanashima A, Shibata K, Nakayama T, Tobinaga S, et al. Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma. Ann Surg Oncol. 2009;16(8):2130–7.PubMedCrossRef Nanashima A, Shibata K, Nakayama T, Tobinaga S, et al. Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma. Ann Surg Oncol. 2009;16(8):2130–7.PubMedCrossRef
34.
Zurück zum Zitat Yao X, Qian CN, Zhang ZF, et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res. 2007;13:161–9.PubMedCrossRef Yao X, Qian CN, Zhang ZF, et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res. 2007;13:161–9.PubMedCrossRef
35.
Zurück zum Zitat Papadopoulos I, Giatromanolaki A, Koukourakis MI, Sivridis E. Tumour angiogenic activity and vascular survival ability in bladder carcinoma. J Clin Pathol. 2004;57:250–25.PubMedCrossRef Papadopoulos I, Giatromanolaki A, Koukourakis MI, Sivridis E. Tumour angiogenic activity and vascular survival ability in bladder carcinoma. J Clin Pathol. 2004;57:250–25.PubMedCrossRef
36.
Zurück zum Zitat Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Invading edge vs. inner’ (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol. 2000;192:140–9.PubMedCrossRef Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Invading edge vs. inner’ (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol. 2000;192:140–9.PubMedCrossRef
37.
Zurück zum Zitat Giatromanolaki A, Sivridis E, Simopoulos C, et al. Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer. Clin Exp Metastasis. 2002;19:673–9.PubMedCrossRef Giatromanolaki A, Sivridis E, Simopoulos C, et al. Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer. Clin Exp Metastasis. 2002;19:673–9.PubMedCrossRef
38.
Zurück zum Zitat Reinmuth N, Parikh AA, Ahmad SA, et al. Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech. 2003;60:199–207. Review.PubMedCrossRef Reinmuth N, Parikh AA, Ahmad SA, et al. Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech. 2003;60:199–207. Review.PubMedCrossRef
Metadaten
Titel
Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors
verfasst von
Luciana Regina Moreira
André Almeida Schenka
Paulo Latuf-Filho
André Lisboa Penná
Carmen S. P. Lima
Fernando Augusto Soares
Miriam Aparecida Silva Trevisan
José Vassallo
Publikationsdatum
01.06.2011
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 3/2011
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-010-0147-0

Weitere Artikel der Ausgabe 3/2011

Tumor Biology 3/2011 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.